Abstract
OBJECTIVE: Farnesyl diphosphate synthase (FPPs) produces FPP which is considered a branch-point intermediate in the synthesis of sterols and isoprenylated cellular metabolites. In this study we investigated whether detectable FPPs activity was present in human colorectal cancer (CRC), also evaluating in vitro the role of this enzyme in the growth and apoptosis of CRC cells by using Pamidronate (PAM), a FPPs activity inhibitor. METHODS: The activity level of FPPs was determined in CRC and the normal surrounding mucosa of 50 patients by radiochemical assay. The FPPs mRNA expression was investigated in 15 of 50 patients by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). K-ras mutation was evaluated using PCR and restriction enzyme analysis. Cell growth and apoptosis, after PAM treatment, in human CRC cell line DLD-1 were measured by MTT test and DNA fragmentation, respectively. RESULTS: FPPs activity was detectable in human CRC. FPPs activity and its mRNA were significantly more abundant in cancer samples than in normal mucosa. In vitro PAM resulted in a significant reduction of cell growth and also gave rise to a marked proapoptotic effect. CONCLUSIONS: This study provides the first evidence of the presence of FPPs activity in human CRC. Moreover, FPPs enzyme was found to play a significant role in colon cancer proliferation. Copyright (c) 2004 S. Karger AG, Basel
| Original language | English |
|---|---|
| Pages (from-to) | 351-358 |
| Number of pages | 8 |
| Journal | Oncology |
| Volume | 67 |
| Issue number | 5-6 |
| Publication status | Published - 2004 |
Fingerprint
ASJC Scopus subject areas
- Cancer Research
- Oncology
Cite this
Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis. / Notarnicola, Maria; Messa, Caterina; Cavallini, Aldo; Bifulco, Maurizio; Tecce, Mario Felice; Eletto, Davide; Di Leo, Alfredo; Montemurro, Severino; Laezza, Chiara; Caruso, Maria Gabriella.
In: Oncology, Vol. 67, No. 5-6, 2004, p. 351-358.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Higher farnesyl diphosphate synthase activity in human colorectal cancer inhibition of cellular apoptosis.
AU - Notarnicola, Maria
AU - Messa, Caterina
AU - Cavallini, Aldo
AU - Bifulco, Maurizio
AU - Tecce, Mario Felice
AU - Eletto, Davide
AU - Di Leo, Alfredo
AU - Montemurro, Severino
AU - Laezza, Chiara
AU - Caruso, Maria Gabriella
PY - 2004
Y1 - 2004
N2 - OBJECTIVE: Farnesyl diphosphate synthase (FPPs) produces FPP which is considered a branch-point intermediate in the synthesis of sterols and isoprenylated cellular metabolites. In this study we investigated whether detectable FPPs activity was present in human colorectal cancer (CRC), also evaluating in vitro the role of this enzyme in the growth and apoptosis of CRC cells by using Pamidronate (PAM), a FPPs activity inhibitor. METHODS: The activity level of FPPs was determined in CRC and the normal surrounding mucosa of 50 patients by radiochemical assay. The FPPs mRNA expression was investigated in 15 of 50 patients by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). K-ras mutation was evaluated using PCR and restriction enzyme analysis. Cell growth and apoptosis, after PAM treatment, in human CRC cell line DLD-1 were measured by MTT test and DNA fragmentation, respectively. RESULTS: FPPs activity was detectable in human CRC. FPPs activity and its mRNA were significantly more abundant in cancer samples than in normal mucosa. In vitro PAM resulted in a significant reduction of cell growth and also gave rise to a marked proapoptotic effect. CONCLUSIONS: This study provides the first evidence of the presence of FPPs activity in human CRC. Moreover, FPPs enzyme was found to play a significant role in colon cancer proliferation. Copyright (c) 2004 S. Karger AG, Basel
AB - OBJECTIVE: Farnesyl diphosphate synthase (FPPs) produces FPP which is considered a branch-point intermediate in the synthesis of sterols and isoprenylated cellular metabolites. In this study we investigated whether detectable FPPs activity was present in human colorectal cancer (CRC), also evaluating in vitro the role of this enzyme in the growth and apoptosis of CRC cells by using Pamidronate (PAM), a FPPs activity inhibitor. METHODS: The activity level of FPPs was determined in CRC and the normal surrounding mucosa of 50 patients by radiochemical assay. The FPPs mRNA expression was investigated in 15 of 50 patients by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). K-ras mutation was evaluated using PCR and restriction enzyme analysis. Cell growth and apoptosis, after PAM treatment, in human CRC cell line DLD-1 were measured by MTT test and DNA fragmentation, respectively. RESULTS: FPPs activity was detectable in human CRC. FPPs activity and its mRNA were significantly more abundant in cancer samples than in normal mucosa. In vitro PAM resulted in a significant reduction of cell growth and also gave rise to a marked proapoptotic effect. CONCLUSIONS: This study provides the first evidence of the presence of FPPs activity in human CRC. Moreover, FPPs enzyme was found to play a significant role in colon cancer proliferation. Copyright (c) 2004 S. Karger AG, Basel
UR - http://www.scopus.com/inward/record.url?scp=13844314055&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=13844314055&partnerID=8YFLogxK
M3 - Article
VL - 67
SP - 351
EP - 358
JO - Oncology
JF - Oncology
SN - 0030-2414
IS - 5-6
ER -